[Clinical effect of intranasal beclomethasone inhalations in chronic vasomotor rhinitis].
D000281:Administration, Intranasal; D000293:Adolescent; D000328:Adult; D001419:Bacteria / Q000302:isolation & purification; D001507:Beclomethasone / Q000008:administration & dosage*; D002176:Candida albicans / Q000302:isolation & purification; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy* / Q000382:microbiology
D010919:Placebos; D001507:Beclomethasone
Het klinische effect van intranasale beclometasoninhalaties bij chronische rhinitis vasomotorica.